Getinge AB (publ) (OTCMKTS:GNGBY) Share Price Passes Above 50 Day Moving Average – Should You Sell?

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $20.30 and traded as high as $22.15. Getinge AB (publ) shares last traded at $22.08, with a volume of 5,574 shares.

Getinge AB (publ) Stock Performance

The company has a current ratio of 0.78, a quick ratio of 0.50 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $6.01 billion, a PE ratio of 38.73 and a beta of 0.81. The firm’s 50-day simple moving average is $20.30 and its two-hundred day simple moving average is $18.76.

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) last announced its quarterly earnings data on Tuesday, January 28th. The company reported $0.49 EPS for the quarter. Getinge AB (publ) had a net margin of 4.71% and a return on equity of 9.84%.

Getinge AB (publ) Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 14th. Investors of record on Thursday, April 24th will be issued a $0.4326 dividend. The ex-dividend date is Thursday, April 24th. This is an increase from Getinge AB (publ)’s previous dividend of $0.42. Getinge AB (publ)’s dividend payout ratio is currently 43.86%.

About Getinge AB (publ)

(Get Free Report)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.

Further Reading

Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.